Wellgistics Health, Inc. (WGRX)

NASDAQ: WGRX · Real-Time Price · USD
3.820
-0.050 (-1.29%)
At close: Mar 28, 2025, 4:00 PM
3.745
-0.075 (-1.96%)
After-hours: Mar 28, 2025, 7:26 PM EDT
-1.29%
Market Cap 198.43M
Revenue (ttm) 18.13M
Net Income (ttm) -6.86M
Shares Out 51.94M
EPS (ttm) -0.15
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 99,257
Open 3.630
Previous Close 3.870
Day's Range 3.524 - 4.091
52-Week Range 2.320 - 5.690
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About WGRX

Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub ... [Read more]

Sector Healthcare
IPO Date Feb 21, 2025
Employees 31
Stock Exchange NASDAQ
Ticker Symbol WGRX
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

Wellgistics Health Achieves SOC 2 Type 1 Compliance, Strengthening Security for AI-Driven Pharmacy Solutions and Employer-Based Healthcare Models

TAMPA, FL, March 18, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ: WGRX) (“Wellgistics Health”), a provider of pharmacy solutions and healthcare technology, has successfully completed a t...

10 days ago - GlobeNewsWire

Wellgistics Health, Inc. Announces Leadership Transition: Brian Norton Appointed as CEO Following Tim Canning's Departure

TAMPA, FL, March 04, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ: WGRX) (the “Company”), a holding company for various existing and planned strategic businesses centered around healthcar...

24 days ago - GlobeNewsWire

Protega Pharmaceuticals collaborates with Wellgistics to support pharmacist education and increase patient access to the first and only FDA-approved abuse-deterrent immediate-release opioid, ROXYBOND™

ROXYBOND, formulated with patented, first-of-its-kind abuse-deterrent technology SentryBond ™ , is designed to provide multiple levels of protection

24 days ago - GlobeNewsWire

Wellgistics Expands Healthcare Ecosystem with Tollo Health Agreement, Targeting Multi-Billion Dollar GLP-1 and Long COVID Market

Tampa, Florida, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ: WGRX, the "Company"), a holding company for various existing and planned strategic businesses centered around health...

4 weeks ago - GlobeNewsWire

Wellgistics Health, Inc. Announces Closing of $4.0 Million Initial Public Offering

Tampa, Florida, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (the "Company"), a holding company for various existing and planned strategic businesses centered around healthcare technolog...

4 weeks ago - GlobeNewsWire

U.S. IPO Weekly Recap: IPO Calendar Slows Down With Small Listings

The calendar slowed down this past week, with only small listings in the US. There was one sizable filing this past week - AIRO Group Holdings. No IPOs are currently scheduled to list in the week ahea...

Other symbols: AURNKMTSNNNNODTXONE
5 weeks ago - Seeking Alpha

Wellgistics Health, Inc. Announces Pricing of $4.0 Million Initial Public Offering

Tampa, Florida, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (the "Company"), a holding company for various existing and planned strategic businesses centered around healthcare technolog...

5 weeks ago - GlobeNewsWire

Danam Health IPO Registration Document (S-1)

Danam Health has filed to go public with an IPO on the NASDAQ.

6 months ago - SEC